Drug Type Chemical drugs |
Synonyms- |
Target |
Action inhibitors |
Mechanism mTOR inhibitors(Serine/threonine-protein kinase mTOR inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| disorder of aging | Preclinical | Switzerland | 16 Feb 2022 | |
| disorder of aging | Preclinical | Switzerland | 16 Feb 2022 | |
| disorder of aging | Preclinical | Switzerland | 16 Feb 2022 |





